Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William M Bennett

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Kidney International|February 3, 2023
Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentationAdriana V Gregory, Fouad T Chebib, Bhavya Poudyal, et al.
Journal of the American Society of Nephrology : JASN|January 21, 2026
Development and Validation of a Multivariable Prediction Model for Kidney Failure in Early Autosomal Dominant Polycystic Kidney DiseaseAlan S L Yu, Aaron Cohen, Vicente E Torres, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 21, 2012
Kidney volume and functional outcomes in autosomal dominant polycystic kidney diseaseArlene B Chapman, James E Bost, Vicente E Torres, et al.
Kidney International Reports|April 29, 2021
Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney DiseaseMireille El Ters, Pengcheng Lu, Jonathan D Mahnken, et al.
Kidney International|November 25, 2003
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney diseaseBernard F King, Vicente E Torres, Marijn E Brummer, et al.
The New England Journal of Medicine|May 19, 2006
Volume progression in polycystic kidney diseaseJared J Grantham, Vicente E Torres, Arlene B Chapman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney diseaseVicente E Torres, Bernard F King, Arlene B Chapman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohortKyongtae T Bae, Fang Zhu, Arlene B Chapman, et al.
Kidney International|September 16, 2011
Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)Gary R Matzke, George R Aronoff, Arthur J Atkinson, et al.
Journal of the American Society of Nephrology : JASN|October 13, 2006
Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney diseasePeter C Harris, Kyongtae T Bae, Sandro Rossetti, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Kidney International|February 3, 2023
Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentationAdriana V Gregory, Fouad T Chebib, Bhavya Poudyal, et al.
Journal of the American Society of Nephrology : JASN|January 21, 2026
Development and Validation of a Multivariable Prediction Model for Kidney Failure in Early Autosomal Dominant Polycystic Kidney DiseaseAlan S L Yu, Aaron Cohen, Vicente E Torres, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 21, 2012
Kidney volume and functional outcomes in autosomal dominant polycystic kidney diseaseArlene B Chapman, James E Bost, Vicente E Torres, et al.
Kidney International Reports|April 29, 2021
Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney DiseaseMireille El Ters, Pengcheng Lu, Jonathan D Mahnken, et al.
Kidney International|November 25, 2003
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney diseaseBernard F King, Vicente E Torres, Marijn E Brummer, et al.
The New England Journal of Medicine|May 19, 2006
Volume progression in polycystic kidney diseaseJared J Grantham, Vicente E Torres, Arlene B Chapman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney diseaseVicente E Torres, Bernard F King, Arlene B Chapman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohortKyongtae T Bae, Fang Zhu, Arlene B Chapman, et al.
Kidney International|September 16, 2011
Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)Gary R Matzke, George R Aronoff, Arthur J Atkinson, et al.
Journal of the American Society of Nephrology : JASN|October 13, 2006
Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney diseasePeter C Harris, Kyongtae T Bae, Sandro Rossetti, et al.
Pageof 9